These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3337048)

  • 1. The relationship of intralaboratory bias and imprecision on laboratories' ability to meet medical usefulness limits.
    Ehrmeyer SS; Laessig RH
    Am J Clin Pathol; 1988 Jan; 89(1):14-8. PubMed ID: 3337048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the use of fixed limits to characterize intralaboratory performance by proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Oct; 33(10):1901-2. PubMed ID: 3665047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of computer modeling to predict the magnitude of intralaboratory error tolerated by proposed CDC interlaboratory proficiency testing performance criteria.
    Laessig RH; Ehrmeyer SS
    Clin Chem; 1988 Sep; 34(9):1849-53. PubMed ID: 2843307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory proficiency-testing programs: a computer model to assess their capability to correctly characterize intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):784-7. PubMed ID: 3594814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1990 Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass.
    Ehrmeyer SS; Laessig RH; Leinweber JE; Oryall JJ
    Clin Chem; 1990 Oct; 36(10):1736-40. PubMed ID: 2170059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the ability of proficiency testing programs to determine intralaboratory performance. Peer group statistics vs clinical usefulness limits.
    Ehrmeyer SS; Laessig RH
    Arch Pathol Lab Med; 1988 Apr; 112(4):444-8. PubMed ID: 3355346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaboration between pharmacy and laboratory: defining total allowable error limits for therapeutically monitored drugs.
    Radomski KM; Bush BA; Ensom MH
    Ann Pharmacother; 1998 Feb; 32(2):170-5. PubMed ID: 9496399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralaboratory performance requirements necessary to pass proficiency testing: CAP-1990 vs CLIA-1967 (March 14, 1990) formats compared.
    Laessig RH; Ehrmeyer SS; Leinweber JE
    Clin Chem; 1992 Jun; 38(6):895-903. PubMed ID: 1597015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conceptual model for establishing tolerance limits for analytic bias and imprecision based on variations in population test distributions.
    Klee G
    Clin Chim Acta; 1997 Apr; 260(2):175-88. PubMed ID: 9177912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study to examine the accuracy of potassium measurements in clinical laboratories across Canada.
    Haag MD; Kelly JR; Ho A; Seccombe DW
    Clin Biochem; 2000 Aug; 33(6):449-56. PubMed ID: 11074236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of interlaboratory precision criteria in measuring intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1985 Aug; 31(8):1352-4. PubMed ID: 3926347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision of autoantibody assays in clinical diagnostic laboratories: What is the reality?
    Senant M; Musset L; Chyderiotis G; Guis-Cabanne L; Damoiseaux J; Fabien N; Dragon-Durey MA
    Clin Biochem; 2020 Sep; 83():57-64. PubMed ID: 32505738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of the 1(2)s rule to detect substandard performance in interlaboratory proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):788-91. PubMed ID: 3594815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of outcome-related analytic performance goals.
    Klee GG
    Clin Chem; 2010 May; 56(5):714-22. PubMed ID: 20348409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coefficient of analysis, a new figure of merit for laboratory performance.
    Louderback AL; Szatkowski PR
    Clin Chem; 1980 May; 26(6):774-5. PubMed ID: 7371158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytic bias specifications based on the analysis of effects on performance of medical guidelines.
    Klee GG; Schryver PG; Kisabeth RM
    Scand J Clin Lab Invest; 1999 Nov; 59(7):509-12. PubMed ID: 10667688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications.
    Petersen PH; Jensen EA; Brandslund I
    Clin Chem Lab Med; 2011 Dec; 50(5):819-31. PubMed ID: 22628319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proficiency testing performance: a case study with modeling.
    Waugh JM; Collier CP; Day AG; Waugh M; Raymond MJ
    Clin Biochem; 2002 Sep; 35(6):447-53. PubMed ID: 12413605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.